GLP-1 Science
What Is the GLP-1 Hormone and What Does It Do in Your Body?
GLP-1 (glucagon-like peptide-1) is the gut hormone that signals fullness after eating. Here is what it does, where it co...
A GLP-1 receptor agonist is a drug that activates GLP-1 receptors in the body — mimicking the effects of your own GLP-1 hormone but in a more sustained, potent way. Ozempic, Wegovy, Mounjaro, and Saxenda are all GLP-1 receptor agonists or partial agonists (Mounjaro adds a second target). Understanding what this class of drugs is explains why they work, why they are different from older approaches, and why they have transformed obesity medicine.
What GLP-1 Is and What It Does
GLP-1 (glucagon-like peptide-1) is a hormone produced naturally by L-cells in your small intestine and colon after every meal. Within minutes of eating, your gut releases GLP-1, which:
- Signals the hypothalamus (brain's hunger centre) to reduce appetite and create satiety
- Slows gastric emptying — food leaves the stomach more slowly, extending fullness
- Stimulates insulin release from the pancreas in response to rising blood sugar
- Suppresses glucagon — the hormone that tells the liver to release stored glucose
Natural GLP-1 has a half-life of only two to three minutes in circulation before the DPP-4 enzyme breaks it down. This is why you feel full after eating but hungry again hours later — the GLP-1 signal is self-limiting by design.
What a GLP-1 Receptor Agonist Does Differently
A GLP-1 receptor agonist is a synthetic molecule engineered to bind the same GLP-1 receptors but resist the DPP-4 breakdown that eliminates natural GLP-1.
Semaglutide, for example, shares 94% sequence identity with native GLP-1 but has been modified to have a half-life of approximately seven days. A single weekly injection maintains continuous GLP-1 receptor activation throughout the week — something that would require your gut to release GLP-1 continuously.
The result: the satiety signal your brain receives after eating a full meal is maintained all week, not just for two minutes.
How the Class Works in Practice
The sustained receptor activation produces the clinically meaningful effects:
Reduced hunger: The hypothalamus receives continuous satiety signalling, reducing between-meal hunger and food reward activation (cravings). Patients report genuinely not wanting to eat rather than fighting hunger — a different experience from willpower-based restriction.
Extended meal fullness: Each meal keeps you physically full for longer than it would without the drug, because gastric emptying is delayed.
Improved blood sugar: Insulin secretion is stimulated when blood sugar rises (glucose-dependent — it does not cause hypoglycaemia when blood sugar is normal), and glucagon is suppressed, reducing post-meal blood sugar peaks.
Cardiovascular benefit: Semaglutide (Wegovy) showed 20% reduction in major cardiovascular events in the SELECT trial — a benefit beyond its weight and glucose effects.
The Different GLP-1 Receptor Agonists
| Drug | Brand | Delivery | Weekly or Daily | Approved For | |---|---|---|---|---| | Semaglutide | Ozempic | Injection | Weekly | Diabetes | | Semaglutide | Wegovy | Injection | Weekly | Obesity | | Semaglutide | Rybelsus | Oral tablet | Daily | Diabetes | | Liraglutide | Victoza | Injection | Daily | Diabetes | | Liraglutide | Saxenda | Injection | Daily | Obesity | | Dulaglutide | Trulicity | Injection | Weekly | Diabetes | | Exenatide | Byetta | Injection | Twice daily | Diabetes | | Tirzepatide | Mounjaro | Injection | Weekly | Diabetes (dual GLP-1/GIP) | | Tirzepatide | Zepbound | Injection | Weekly | Obesity (dual GLP-1/GIP) |
How GLP-1 Pathway Access Works Without Pharmaceutical Drugs
The same GLP-1 receptors can be activated through routes other than pharmaceutical injection. METASLIM uses sublingual delivery — absorbing GLP-1 directly into the bloodstream from under the tongue — to activate the same receptor system. It is DRAP-registered and physician-guided, providing GLP-1 receptor pathway access for Pakistani patients for whom pharmaceutical GLP-1 agonist injection is unavailable.